RxDoctor Payments DataLook up a doctor →

Calvin Rushing, DPM

Podiatrist · Sunnyvale, TXNPI 1497109433

Payments from drug & device makers

$461,852in general payments, 2019–2025

Across 413 payments — averaging $1118.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bone Support Inc.$76K
  • Flower Orthopedics Coporation$61K
  • Medshape, Inc.$50K
  • Fusion Orthopedics USA, LLC$48K
  • New Standard Device, LLC Dba Metalogix$39K
  • Alafair Biosciences, Inc.$33K
  • plus $155K from 49 others
$24,902in research payments, 2019–2025

Across 6 payments — averaging $4150.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acera Surgical, Inc.$22K
  • Tyber Medical, LLC$3K

What the payments were for

  • Royalty or licence$9600%
  • Consulting fees$363,23880%
  • Speaking & faculty fees$40,8009%
  • Travel & lodging$23,0565%
  • Food & beverage$13,8743%
  • Education$1,1670%
  • Charitable contribution$8,0002%
  • Ownership interest$7180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$461,852 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas

Medicare billing

Part B allowed, 2024
$69,097
Medicare patients
98
Services billed
976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc94$3,149
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen120$1,333
Celecoxib92$1,286
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav75$1,192
Doxycycline Monohydrate43$964
Mupirocin50$508
Clindamycin Hcl16$457
Doxycycline Hyclate25$394
Pregabalin48$370
Methylprednisolone37$319
Ciprofloxacin Hcl20$208
Tramadol Hcl20$93
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$67
Meloxicam21$46

Paid to pharmacies, not to this prescriber.

Other podiatrist in Sunnyvale

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →